PO Box 1488
Warrenville, IL 60555
Phone: 331.248.7888
Email: sidp@affinity-strategies.com
Host Erin McCreary (@erinmccreary) and expert panelists Dr. Katie Barber (@IDKatieBarb), Dr. Warren Rose (@Warren_E_Rose), and Dr. Steven Tong (@syctong) discuss data from early laboratory work to randomized, clinical trials for various antibiotic combinations used in the treatment of MRSA bacteremia. This was our most requested topic to cover on Breakpoints, and we hope you enjoy!
Please complete this brief survey to help us continue to improve Breakpoints content: https://docs.google.com/forms/d/e/1FAIpQLSeriW-TAgiBik2_gdJllCZ4WqADhUyFIZtTAgYAYxRU5YU3hA/viewform?vc=0&c=0&w=1&flr=0
Katie Barber, PharmD
Dr. Katie Barber is an Associate Professor at the University of Mississippi School of Pharmacy. She completed both a residency in Infectious Diseases at Detroit Medical Center and an Infectious Diseases PK/PD fellowship at Wayne State University. Her current role is as a clinical pharmacist and rounds on the inpatient infectious diseases consult service at the University of Mississippi Medical Center.
Warren Rose, PharmD, MPH
Dr. Warren Rose is an Associate Professor at the University of Wisconsin Madison School of Pharmacy as well as an Adjunct professorship with the school of medicine. He also has a clinical practice appointment within the University of Madison Health System. His research interests include antimicrobial pharmacology and resistance.
Steven Tong, PhD, FRACP, MBBS (Hons)
Associate professor Steven Tong is an Infectious Diseases physician with the Victorian Infectious Diseases service and cohead of the Translational and Clinical Research and Indigenous Health crosscutting discipline at the Doherty Institute. His research interests include skin pathogens, and has named two new species of Staphylococcus.
